PHILADELPHIA, Aug. 20 /PRNewswire/ -- Peer-reviewed safety and efficacy
data on Electrical Twitch Obtaining Intramuscular Stimulation (eToims(R)),
successfully applied to patients suffering from treatment-resistant chronic
pain appeared in the August/September issue of Electromyography and Clinical
Neurophysiology. The findings reported by University of Pennsylvania
associated physicians Jennifer Chu, M.D. and Ira Schwartz, M.D., Ph.D.,
represent an important advancement in understanding this debilitating disease.
"Seventy-six million Americans, including Olympic athletes suffer from
constant long-standing muscle pain, for which treatment is elusive", says Dr.
Chu, Associate Professor of Physical Medicine and Rehabilitation, and faculty
at the University of Pennsylvania's Medical School for over 30 years. "This
study demonstrates a ground-breaking, non-invasive and drug-free approach that
controls and may ultimately eliminate the most common cause of muscle pain".
eToims(R)-related neuromuscular pain research began in 1990, combining
5,000-year-old art of acupuncture with modern technology applied to anatomical
and neurophysiological science. In 2006, eToims(R) became non-invasive
replacing needle use with a handheld electrical wand. eToims(R) produces
muscle twitches by stimulating deep neuromuscular junctions at multiple body
areas relieving muscle tightness, differentiating it from all other invasive
and noninvasive neuromuscular stimulation.
The results were from 92 patients aged 20 to 82 years, with long standing,
treatment non-responsive muscle pain, who paid for ongoing eToims(R)
treatments. Pain relief was more definitive in those receiving 3Hz frequency
electrical stimulation for 4 seconds than 1Hz for 1 second, establishing the
therapeutic importance of low-frequency repetitive stimulation. There were no
noted complications or adverse effects from weekly or bi-weekly treatments
applied over 18 months.
Twitch-induced pain relief results from effective internal stretching of
nerve-related, pain producing shortened muscles. The scientific deep massage
effects relax muscles, release entrapped nerves, decrease traction on pain-
sensitive structures, increase oxygen-rich blood inflow to, and pain-producing
chemical outflow from affected areas.
eToims(R) Medical Technology, LLC developed and patented the eToims(R)
system (www.stopmusclepain.com) and was recently named one of Philadelphia's
Top 3 Emerging Biotechnology Companies by Benjamin Franklin Technology
Partners. In September, the company will present at AdvaMed 2008: The MedTech
Conference (www.advamed2008.com) in Washington D.C. eToims(R) Medical
Technology is expected to receive relevant U.S. and European regulatory
clearance before the end of 2008.
.gif)
